Table 1. Uni- and multivariate analysis of MFS in the luminal BC public data.

		Univariate			Multivariate
		N	HR [95CI]	p	N	HR [95CI]	p
Age	>50 vs < = 50 y	512	1.03 [0.73–1.46]	0,87
pT	pT2-3 vs pT1	556	1.76 [1.25–2.48]	1,30E-03	509	1.51 [1.05–2.18]	2,65E-02
pN	pos vs neg	829	1.21 [0.9–1.63]	0,22
SBR grade	2–3 vs 1	650	2.72 [1.69–4.4]	4,22E-05	509	1.39 [0.82–2.34]	0,22
Histology **	ILC vs IDC	128	1.45 [0.59–3.56]	0,41
	other vs IDC	128	0.78 [0.18–3.29]	0,73
Hormone therapy	Yes vs No	746	0.64 [0.45–0.93]	2,01E-02	509	0.68 [0.41–1.12]	0,13
Chemotherapy	Yes vs No	749	1.08 [0.71–1.66]	0,71
ERBB2 IHC status	pos vs neg	148	1.19 [0.36–3.91]	0,77
Molecular subtype *	LumB vs lumA	1016	2.07 [1.67–2.57]	3,99E-11	509	2.53 [1.66–3.87]	1,66E-05
RECQL4		1016	1.55 [1.37–1.75]	1,44E-12	509	1.33 [1.02–1.73]	3,40E-02

as previously defined [4].

IDC: infiltrated ductal carcinomas; ILC: infiltrated lobular carcinomas.